60kVp双低剂量冠状动脉CT血管学与深度学习重建算法的临床可行性测试
Xi Wu1, Manman Zhu2, Yixuan Zou2
1Department of Radiology, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, China.
Insights into imaging
|February 10, 2026
概括
这项研究表明,使用深度学习重建 (DLR) 的60kVp双低剂量冠状动脉CT血管造影 (CCTA) 显著降低了辐射和对比剂量. DLR算法在评估冠状动脉狭窄和CT衍生的分流储量 (CT-FFR) 中保持了高准确性,证明了其临床可行性.
科学领域:
- 心血管成像 - 心血管成像
- 放射学 放射学是一门学科.
- 人工智能在医学中的应用
背景情况:
- 冠状动脉CT血管造影 (CCTA) 对于诊断冠状动脉疾病至关重要.
- 辐射和对比剂量降低是CCTA的重大挑战.
- 深度学习重建 (DLR) 算法显示,在较低剂量下改善图像质量是有前途的.
研究的目的:
- 评估60kVp双低剂量CCTA协议的可行性.
- 在本协议中评估深度学习重建 (DLR) 算法的性能.
- 为了比较诊断准确度和CT衍生分流储备 (CT-FFR) 与常规剂量CCTA的一致性.
主要方法:
- 预计将89名疑似冠状动脉疾病的患者招募.
- 双采集协议:60kVp双低剂量CCTA,然后是常规剂量CCTA.
- 在低剂量 (LD-HIR,LD-DLR) 和常规剂量 (RD-HIR) 重建之间比较图像质量,狭窄性评估和CT-FFR.
主要成果:
- 显著减少辐射剂量 (86.5%) 和对比度体积 (36.4%) 与60kVp协议.
- 与LD-HIR相比,LD-DLR显示出更高的特异性,积极的预测值和检测冠状动脉狭窄的准确性.
- LD-DLR实现的图像质量 (IQS,SNR,CNR) 不低于常规剂量混合代重建 (RD-HIR).
结论:
- 60kVp双低剂量CCTA协议与DLR是可行的临床应用.
- DLR有效地保持了冠状动脉狭窄和CT-FFR评估的诊断性能.
- 这种方法可以显著降低剂量,而不会影响诊断疗效.
相关概念视频
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
447
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
447
Coronary Artery Disease III: Clinical Manifestations
411
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
411
Trial and Error and Algorithm
429
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
429
Coronary Circulation
7.5K
The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.5K
Dose Size and Dosing Frequency: Determination Methods
320
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
320
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
250
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
250


